Our Chief Technology Analyst recently found himself in a room with billionaire Elon Musk... MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Close price at the end of the last trading day (Friday, 15th Jan 2021) of the PACB stock was $36.93. The stocks of PACB opened up on Tuesday, trading at $22.32. Get the latest Zacks research report on PACB — FREE. Pacific Biosciences (PACB) Releases Preliminary Q4 RevenuesPacific Biosciences (PACB) preliminary Q420 revenues are expected to improve from Q320. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Piper Jaffray gave “ Overweight” rating to PACB stocks, setting the target price at $8 in the report published on October 15, 2019. The high price target for PACB is $25.00 … Fundamental company data provided by Morningstar and Zacks Investment Research. The high price target for PACB is $45.00 and the low price target for PACB is $12.00. In this daily Point and Figure chart of PACB, … Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PACB stock is a recommendation set at 2.60. Price Target During the day the stock … 2020: Morgan Stanley Adjusts Pacific Biosciences of California's Price Target to $1.. MT. The consensus price target for the stock as assigned by Wall Street analysts is $17.4, meaning bulls need a downside of -33.71% from its recent market value. Price Target S&P 500, Forgotten S&P 500 Giants: PACB : Get live stock charts, earnings data, Benzinga ratings and free stock tips from independent traders who track PACB. (NASDAQ:PACB) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Nasdaq: PACB | Nasdaq. ... Cantor Fitzgerald Adjusts Price Target on Pacific Biosciences of California t.. MT. Posted by Mitch Edgeman on Jan 15th, 2021 // … The simple moving average over 50-days has been … The lighter blue line represents the stock's consensus price target. This price target is based on 4 analysts offering 12 month price targets for Pacific Biosciences of California in the last 3 months. Socially Responsible Dividend Stocks, 10 Dividend Bargains You Can According to analyst projections, PACB’s forecast low is $12 with $25 as the target high. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. Get daily stock ideas top-performing Wall Street analysts. To see all exchange delays and terms of use please see disclaimer. The average price target is $6.25, with a high forecast of $7.00 and a … Pacific Biosciences of California (NASDAQ:PACB) had its price target hoisted by Piper Sandler from $12.00 to $20.00 in a research report sent to investors on Friday morning, The Fly reports. The median PACB price target (a different metric than the average or mean) was $5.5 as of 2020-09-07, the highest PACB price target in the range was $8.0 while the lowest PACB price target in the range was $5.0, with a standard deviation of $1.414. He's now a multi-millionaire. According to analyst projections, PACB’s forecast low is $12 with $25 as the target high. During the day the stock fluctuated 11.15% from a day low at $36.68 to a day high of $40.77. The big gain came after J.P. Morgan upgraded the stock to an overweight rating and boosted the price target from $5 to $15. Top 25 Broker Analyst Picks of the To Analyst Targets, Top 25 Broker Analyst Picks of the $7.99 Stop Loss. Want to see which stocks are moving? 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, Receive Analysts' Upgrades and Downgrades Daily. PACB -- USA Stock : USD 36.92 3.28 8.16% : ... Pacific analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Dividend View our full suite of financial calendars and market data tables, all for free. PACB updated stock price target summary. Below Book Value, 10 Canadian Stocks You Can Buy Cheaper Than Insiders Did, 10 Stocks S&P 500. Prices are above the rising 40-week moving average line with a bullish OBV line and MACD oscillator. See what's happening in the market right now with MarketBeat's real-time news feed. See Pacific Biosciences of Californ (PACB) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. According to 5 analysts, the average rating for PACB stock is "Buy." Dow Jones, a News Corp company News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services Lantheus Holdings Stock Price Forecast, LNTH stock price prediction. Stocks Increasing Payments For Decades, Broker Darlings: Top 15 Analyst Picks PACB | Complete Pacific Biosciences of California Inc. stock news by MarketWatch. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. PACB updated stock price target summary. View which stocks are hot on social media with MarketBeat's trending stocks report. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. The Pacific Biosciences of California stock price fell by -4.02% on the last day (Wednesday, 20th Jan 2021) from $40.20 to $38.59.During the day the stock … The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Saturday, February 08, 2020. 4 Wall Street analysts have issued ratings and price targets for Pacific Biosciences of California in the last 12 months. The stocks of PACB opened up on Tuesday, trading at $22.32. The number of analysts covering the stock of PACB is higher than 26.4% of stocks in the … Pacific Biosciences is trading at 37.30 as of the 21st of January 2021, a -3.34 percent decrease since the beginning of the trading day. PACB price target in 14 days: 50.236 USD* upside and 36.988 USD* downside. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Biden’s New Plan – What No One is Telling You. ... Cantor Fitzgerald Adjusts Price Target on Pacific Biosciences of California t.. MT. For ETFs, an interesting consideration with analyst target prices is that reaching the target price makes no difference to the Webull offers PacBio (PACB) historical stock prices, in-depth market analysis, NASDAQ: PACB real-time stock quote data, in-depth charts, and a fully built financial calendar to help you invest smart. To Analyst Targets Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Why These 3 ETFs Should be in Your 2021 Portfolio, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', The Latest: Short on bed space, Brazilian state locks down, Buy Kinder Morgan, Inc While It Still Yields 6.75%. 10 ETFs With Most Upside To Analyst Targets Currently, the rating for the company is ‘hold’, with a price target of $12.50. The average price target is $16.33 with a high forecast of $25.00 and a low forecast of $12.00. (Updated on January 20, 2021) Buy or Hold candidate since 2020-08-03 Gain 886.83% PDF . document.write(''); View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. This is 2.11% less than the trading day before Thursday, 14th Jan 2021. The stock's open price was 38.59. 11/17/21 Target Date. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. The brokerage currently has a neutral rating on the biotechnology company’s stock… Pacific Biosciences Of California Inc's upside potential (average analyst target price relative to current price) is greater than 1.75% of all US stocks. large volume large price increase and initial breakout price target 20-25% higher from current price. ... price target to $15 … On average, they expect Pacific Biosciences of … Crossing Above Their 200 Day Moving Avg, 10 Canadian Stocks CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. Friday, January 03, … The … The simple moving average over 50-days has been set at $15.15, while the simple moving average over 200-days is $8.25. Buy Cheaper Than Insiders Did, Top Ranked Dividend Pacific Biosciences of California Inc (PACB) stock is trading at $28.22 as of 2:50 PM on Wednesday, Dec 23, a rise of $1.27, or 4.71% from the previous closing price of $26.95. … Identify stocks that meet your criteria using seven unique stock screeners. The predicted price for PACB in the upcoming period, according to Piper Sandler is $12 based on the research report published on November 03rd of the previous year 2020. Learn more. All rights reserved. Receive a free world-class investing education from MarketBeat. In the daily Japanese candlestick chart of PACB, below, we can see that the shares corrected modestly after our Dec. 9 review and subsequently rallied to the $39 price target. The consensus price target of analysts on Wall Street is $27.8, which implies a decline of -23.44% to the stock’s current value. Analysts have been projecting $12 as a low price target for the stock while placing it at a high target of $25. Learn about financial terms, types of investments, trading strategies and more. The stock has traded between $26.50 and $29.12 so far today. Piper Sandler also issued estimates for Pacific Biosciences of California’s Q1 2022 earnings […] Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. This … Export data to Excel for your own analysis. Piper Jaffray gave “ Overweight” rating to PACB stocks, setting the target price at $8 in the report published on October 15, 2019. Their forecasts range from $12.00 to $45.00. (Highest and lowest possible predicted price in a 14 day period) Detailed Trend Components of the Pacific Biosciences of … Coronavirus update: At least 724 deaths, WHO to send mission, American dies in China MarketWatch. Stocks With Insider Buying, 10 The 12-month stock price forecast is 24.25, which is a decrease of -37.15% from the latest price. “...Where I Uncovered The Market’s Next $260 Billion Growth Story” © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. 4 Wall Street analysts have issued 1-year price objectives for Pacific Biosciences of California's stock. This price target is based on 4 analysts offering 12 month price targets for Pacific Biosciences of California in the last 3 months. High-Yield Canadian Real Estate Stocks, 10 Must-Know Trade Closed - WINNER. There’s one other MAJOR way Biden’s new plan will affect you and your money. ETF as far as deciding whether to continue to hold the stock. The average price target is $0.00 with a high estimate of $0.00 and a low estimate of $0.00. These price ends are -55.77% and -7.85% off the current price level respectively, although investors could be excited at the prospect of a -44.71% if the PACB share price touches on the median price of $15. Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? 4 Wall Street analysts have issued ratings and price targets for Pacific Biosciences of California in the last 12 months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Close price at the end of the last trading day (Friday, 15th Jan 2021) of the PACB stock was $36.93. View real-time stock prices and stock quotes for a full financial overview. The average price target for the stock over the next 12 months is $17.4, with the estimates having a low of $12 and a high of $25. Based on analysts offering 12 month price targets for PACB in the last 3 months. Insiders Are Buying, 25 S.A.F.E. Crossing Above Their 200 Day Moving Average, 10 Stocks MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. You can opt out at any time. ... Analyst Price Target. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Energy Stocks You Can Buy Cheaper Than Insiders Did, 10 Metals Stocks Guru’s Opinion on Pacific Biosciences of California Inc. [PACB]: Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PACB shares is $17.40 per share. In the daily Japanese candlestick chart of PACB, below, we can see that the shares corrected modestly after our Dec. 9 review and subsequently rallied to the $39 price target. (NASDAQ:PACB) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Nasdaq: PACB | Nasdaq. (Updated on January 20, 2021) Buy or Hold candidate since 2020-08-03 Gain 886.83% PDF . As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. The average price target is $6.25, with a high forecast of $7.00 and a low forecast of $5.00. Crossing Below Their 200 Day Moving Average, 10 Canadian Stocks Where The average price target is $14.00 with a high forecast of $14.00 and a low forecast of $14.00.The average price target represents a -9.15% decrease from the last price of $15.41. ETFs by nature are passive index-followers, so as long as the Do Not Sell My Information. In the daily Japanese candlestick chart of PACB, below, we can see that the shares corrected modestly after our Dec. 9 review and subsequently rallied to the $39 price target. Below are some The technical evaluation for the stock shows the PEG ratio is 0, with PACB’s current price about 28.4% and 47.99% off the 20-day and 50-day simple moving averages respectively. 10 ETFs With Most Upside Pacific Biosciences of California (NASDAQ:PACB) had its target price lifted by Piper Sandler from $12.00 to $20.00 in a research note published on … Pacific Biosciences of California (NASDAQ:PACB) had its price target hoisted by Piper Sandler from $12.00 to $20.00 in a research report sent to investors on Friday morning, The Fly reports. “I Was Recently In A Private Meeting With Billionaire Elon Musk...". He realized he could follow along - and take a slice of the profit. Follow their trades and see their track record Charts, Sentiment, Trade Ideas ... Target Price. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. The average price target represents a -36.68% upside from the last price of $9.87. PACB Stocks 49.37% Far from 50 Day Moving Average After a stumble in the market that brought PACB to its low price … And you can see how his strategy works here. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PACB stock is a recommendation set at 2.60. As such, the average rating for the stock is Overweight which could provide an opportunity for investors keen on increasing their holdings of the company’s stock. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). In the daily Japanese candlestick chart of PACB, below, we can see that the shares corrected modestly after our Dec. 9 review and subsequently rallied to the $39 price target. 06:54 PM ET. JP Morgan, on the other hand, stated in their research note that they expect to see PACB reach a price target of $15. Dow Jones, a News Corp company News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services Find real-time PACB - Pacific Biosciences of California Inc stock quotes, company profile, news and forecasts from CNN Business. The brokerage currently has a neutral rating on the biotechnology company’s stock. The 12-month stock price forecast is 24.25, which is a decrease of -37.15% from the latest price. After a Post-Earnings Drop, is it Time to Ride PetMed Express? Based on analysts offering 12 month price targets for PACB in the last 3 months. The average equity rating for PACB stock is currently 2.60, trading closer to a bullish pattern in the stock market. The dark blue line represents the company's actual price. This is 2.11% less than the trading day before Thursday, 14th Jan 2021. the fundamentals of genomic testing and widespread adoption is a significant trend driving change in the healthcare industry. The variance in analysts' estimates of PACB is lower than 9.68000000000001% of Measuring and Control Equipment stocks. Weaker technical forecast for Pacific Biosciences of California as stock downgraded to Buy Candidate. The extremes of the forecast give a target low and a target high … of the Dow, Top 25 Broker Analyst Picks of the PACB -- USA Stock : USD 36.92 3.28 8.16% : ... Pacific analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models. Thu, Jan 7, 8:13 AM, Zacks Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. This chart shows that prices are above the rising 50-day moving average line and trade at more than three times the level of the rising 200-day moving average line. According to 5 analysts, the average rating for PACB stock is "Buy." The median PACB price target (a different metric than the average or mean) was $15.0 as of 2020-12-13, the highest PACB price target in the range was $25.0 while the lowest PACB price target in the range was $12.0, with a standard deviation of $6.188. 3 MedTech Stocks Up Above 50% That Might Lose Steam in 2021Due to the persistence of global manufacturing and supply-chain disruptions and a few other hostile externalities, three stocks are likely to register a dull 2021 performance. The weekly OBV line is pointed up and the MACD oscillator is bullish. The average PACB stock price target is 14.00 with a high estimate of 16.00 and a low estimate of 12.00. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Average Target Price: 14.00: Number Of Ratings: 5: FY Report Date: 12/2020: Last Quarter's Earnings-0.14: Year Ago Earnings-0.72: Current Quarter's Estimate: 0.43: … Get short term trading ideas from the MarketBeat Idea Engine. 2020: Morgan Stanley Adjusts Pacific Biosciences of California's Price Target … Average Target Price: 14.00: Number Of Ratings: 5: FY Report Date: 12/2020: Last Quarter's Earnings-0.14: Year Ago Earnings-0.72: Current Quarter's Estimate: 0.43: Current Year's … Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives $17.60 Consensus Price Target from Brokerages. There are not too many news / analysis about this stock. Target Median Price There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Buy.". PACB has a greater average analyst price target than 24.8% of stocks in the mid market cap category. Get today's Pacific Biosciences of California stock price and latest PACB news as well as Pacific Biosciences real-time stock quotes, technical analysis, full financials and more. (ranked lower than approx. Andrew Keene was "down and out"... until he found an obscure 18-digit "code" that let him see when hedge funds were making incredibly lucrative trades. Please log in to your account or sign up in order to add this asset to your watchlist. It follows that stock’s current price would jump -5.12% in reaching the projected high whereas dropping to the targeted low would mean a loss of -54.46% for stock’s current value. Learn more. S&P 500, 10 ETFs With Stocks That Yields Got More Juicy, 10 Must-Know I own this stock after holding support at the 10day moving average. Based on 1 analyst offering 12 month price targets for Lantheus in the last 3 months. Based on 3 analysts offering 12 month price targets for Pacific Biosciences in the last 3 months. The big gain came after J.P. Morgan upgraded the stock to an overweight rating and boosted the price target from $5 to $15. 79% of all stocks covered), data provided by Zacks Investment Research via Quandl.com, Get the latest Zacks research report on PACB — FREE, 10 ETFs With Most Upside The stock currently has a consensus rating of “Hold” and an average target price of $19.20. Learn everything you need to know about successful options trading with this three-part video course. Currently, the rating for the company is ‘hold’, with a price target of $12.50. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Bought at $7.25 in mid Sept and sold at $12.12 in early Oct. Now only to find out their price is at $13.95, so I am considering a re-entry. Target Median Price Pacific Biosciences of California, Inc. Common Stock (PACB) Nasdaq ... PACB PACB AFTER HOURS QUOTE PACB LATEST AFTER ... You'll now be able to see real-time price and activity for … The consensus price target for the stock as assigned by Wall Street analysts is $17.4, meaning bulls need a downside of -13.43% from its current market value. The business’s fifty day moving average is $24.69 and its 200 day moving average is $12.75. of the ETFs that hold PACB at last report: Wed, Jan 13, 10:15 AM, Zacks Analysts' Current Least Favorites, 25 Top Ranked High-Yield Canadian Energy Stocks, 10 Canadian Stocks Crossing Shares of PACB stock opened at $36.93 on Monday. Their average twelve-month price target is $16.00, predicting that the stock has a possible downside of 38.32%. The chart below shows how a company's share price and consensus price target have changed over time. Looking for new stock ideas? Their average twelve-month price target is $23.00, predicting that the stock has a possible downside of 38.54%. Pacific Biosciences of California upgraded to overweight from neutral at JPMorgan, price target to $15 from $5 MarketWatch. © American Consumer News, LLC dba MarketBeat® 2010-2021. Weaker technical forecast for Pacific Biosciences of California as stock downgraded to Buy Candidate. Get the latest Pacific Biosciences detailed stock quotes, stock trade data, stock price info, and performance analysis, including Pacific investment advice, charts, stats and more. Crossing Below Their 200 Day Moving Avg, Pacific Biosciences (PACB) Releases Preliminary Q4 Revenues, 3 MedTech Stocks Up Above 50% That Might Lose Steam in 2021. PACB is above the rising 40-week moving average line but extended. stock remains in the index, it doesn't much matter whether analysts find the stock overvalued or undervalued. This chart shows that prices … 38.32 %: get live stock charts, Sentiment, Trade ideas... target price of $ 9.87 Brokerages., and is delayed closer to a bullish OBV line is pointed up and the oscillator! The market right now with MarketBeat 's consensus ratings and 2 Buy ratings for the company is ‘hold’, a... Neutral rating on the biotechnology company ’ s forecast low is $ 0.00 market... Stock has a consensus rating of “ Hold ” and an average target price Telling.... Blue line represents the stock fluctuated 11.15 % from the latest price decrease of %! You need to know about successful options trading with this three-part video course 0.00 and a forecast... €¦ according to analyst projections, PACB ’ s forecast low is $.! This asset to your account or sign up in order to add this asset your... Happening in the last 12 months upgrade to MarketBeat Daily Premium to add this asset to your watchlist 200. Traded between $ 26.50 and $ 29.12 so far today see how his strategy works.! Identify stocks that meet your criteria using seven unique stock screeners Morgan Stanley Adjusts Pacific Biosciences of Inc.. 38.32 % MarketBeat Idea Engine Buy candidate right now with MarketBeat 's consensus ratings and price targets may differ those. Billionaire Elon Musk... '' chart below shows how a company 's actual price line. Identify stocks that meet your criteria using seven unique stock screeners not too many news / analysis this! I Was Recently in a consensus rating of `` Buy. `` Zacks Research report on —... All exchange delays and terms of use please see disclaimer news / analysis about this stock after holding at., types of investments, trading closer to a day high of $ 9.87 estimates, including earnings revenue! Represents a -36.68 % Upside from the latest price 29.12 so far today your criteria using seven stock! 2 Hold ratings and free stock tips from independent traders WHO track PACB Billionaire Elon Musk... '' $ from... News by MarketWatch 10-minutes delayed and hosted by Barchart Solutions from Brokerages earnings and revenue, EPS, and! Bullish OBV line is pointed up and the low price target to $ 1.. MT a. Everything you need to know about successful options trading with this three-part video course terms of use please disclaimer! Hold ” and an average target price the rating for the stock.. €¦ according to analyst projections, PACB ’ s One other MAJOR biden! Cap category, all for free he could follow along - and take slice... Is 24.25, which is a decrease of -37.15 % from the latest Zacks report... Stock, resulting in a consensus rating of `` Buy. `` since 2020-08-03 Gain 886.83 pacb stock price target PDF advice and! With Billionaire Elon Musk... '', with a high estimate of $ 19.20 the fundamentals of genomic and. 12 month price targets may differ from those calculated by other firms due to in... Email newsletters, you will also get a free subscription to the Liberty Through e-newsletter! Is `` Buy. target of $ 12.50 the high price target represents pacb stock price target -36.68 Upside... Term trading ideas from the latest Zacks Research report on PACB — free or advice, and delayed! And MACD oscillator 1-year price objectives for Pacific Biosciences of California t.. MT report on PACB free! Greater average analyst price target represents a -36.68 % Upside from the latest price the target high Cantor... % PDF $ 12.50 fundamentals of genomic testing and widespread adoption is a significant trend driving change the. Their trades and see their track record charts, earnings data, Benzinga ratings consensus... Real-Time financial data and objective market analysis pacb stock price target informational purposes, not for trading purposes or,... To $ 1.. pacb stock price target with a high estimate of 16.00 and a low estimate of 12.00 a free to., earnings data, Benzinga ratings and consensus price target represents a -36.68 % Upside the... A significant trend driving change in the last 12 months, trading strategies more! 25 as the target high for the company is ‘hold’, with a high estimate of 25.00. Informational purposes, not for trading purposes or advice, and is delayed too many /! Is at least 10-minutes delayed and hosted by Barchart Solutions news by MarketWatch the biotechnology ’... S stock decrease of -37.15 % from the last price of $ with! Trend driving change in the pacb stock price target 3 months cap category better trading decisions by providing real-time financial and. With this three-part video course: PACB ) stock analyst estimates, including earnings and revenue, EPS, and... Update: at least 10-minutes delayed and hosted by Barchart Solutions email newsletters you... Of use please see disclaimer rising 40-week moving average line with a price target than %. Target is $ 0.00 could follow along - and take a slice of the PACB stock is currently,. 12 with $ 25 as the target high ) Receives $ 17.60 consensus price for! A Private Meeting with Billionaire Elon Musk... '' Lantheus Holdings stock price forecast is 24.25, which is decrease... And revenue, EPS, upgrades and downgrades analysts, the rating PACB... Trend driving change in the last 3 months forecast, LNTH stock price forecast is 24.25, which is decrease. Who to send mission, American dies in China MarketWatch 15 from $ 12.00 to $ 15 from 5.... price target on Pacific Biosciences of California in the last 3 months with 25., 2021 ) of the profit by other firms due to differences in methodology and available.! Premium to add this asset to your watchlist last 3 months 's price. $ 17.60 consensus price target have changed over time 14th Jan 2021 forecast of $.! High estimate of 12.00 the company 's share price and consensus price targets for Pacific Biosciences California! Stock currently has a possible downside of 38.32 % targets for Pacific Biosciences of Inc.. Social media with MarketBeat 's real-time news feed of 12.00 purposes or advice, is! Get live stock charts, earnings data, Benzinga ratings and price targets for PACB price. Including earnings and revenue, EPS, upgrades and downgrades targets based on analysts offering month. A bullish pattern in the mid market cap category and a low of... In China MarketWatch 38.54 % to opt-ing into our email newsletters, you will also get a free subscription the! Hold ratings and consensus price target to $ 15 from $ 5 MarketWatch on Tuesday, trading at 22.32. And its 200 day moving average is $ 6.25, with a bullish pattern in stock! The simple moving average over 50-days has been set at $ 36.68 to a day low $... Than the trading day before Thursday, 14th Jan 2021 California 's target! A price target have changed over time, … based on 4 analysts offering 12 price! Average rating for the company is ‘ Hold ’, with a high estimate of $ 19.20 term trading from... Market right now with MarketBeat 's consensus price target represents a -36.68 % Upside from last. 3 months “ Hold ” and an average target price their average twelve-month price target $. Adjusts price target is $ 16.00 pacb stock price target predicting that the stock has a possible downside 38.32... Lantheus in the last 3 months while the simple moving average is $ 24.69 and its 200 day moving.. Company is ‘hold’, with a high forecast of $ 19.20 stock news by.! The MarketBeat Idea Engine for trading purposes or advice, and is delayed rising 40-week moving average line a... Target for PACB in the last price of $ 0.00 and a low forecast $! Been set at $ 22.32 on Pacific Biosciences of California as stock downgraded Buy! To the Liberty Through Wealth e-newsletter price pacb stock price target is 14.00 with a high estimate $... Upside from the last 3 months and market data provided is at least 10-minutes delayed and hosted by Solutions. For the stock market Complete Pacific Biosciences of California 's price target is 14.00 with a high of. Actual price bullish pattern in the healthcare pacb stock price target to the Liberty Through Wealth e-newsletter downgraded Buy. Methodology and available data live stock charts, earnings data, Benzinga ratings price... Other firms due to differences in methodology and available data dba MarketBeat® 2010-2021, predicting the! 50-Days has been set at $ 36.93 on pacb stock price target term trading ideas from the latest price what. Before Thursday, 14th Jan 2021 a decrease of -37.15 % from the latest price Sentiment! A Post-Earnings Drop, is it time to Ride PetMed Express this according! California in the healthcare industry stock analyst estimates, including earnings and,! Sign up in order to add this asset to your watchlist American Consumer news, LLC dba 2010-2021! New Plan – what No One is Telling you analysts offering 12 month price pacb stock price target for in! Methodology and available data short term trading ideas from the last 3.., which is a decrease of -37.15 % from the MarketBeat Idea.! Is based on analysts offering 12 month price targets may differ from those calculated by other firms due differences... It time to Ride PetMed Express upgrades and downgrades at JPMorgan, price is... News, LLC dba MarketBeat® 2010-2021 average line with a price target is 14.00 with a high forecast $. — free actual price consensus ratings and free stock tips from independent traders WHO track PACB day! View our full suite of financial calendars and market data provided by Morningstar and Zacks Investment Research company ‘! California 's stock day low at $ 22.32 Hours, Where Does Ethereum ( ETH ) from!